Dr. Jerome Bernard Zeldis, also known as Jerry, M.D., Ph.D., has been the Chief Medical Officer and President of Clinical Development at Sorrento Therapeutics, Inc. since August 15, 2016.
Zeldis on Feb. 3, 2017 bought 10,000 at $5.15 for a total of 51.5K. He owns a total of 10,000 shares.
Dr. Zeldis served as the Chief Medical Officer, Senior Vice President of Clinical Research & Medical Development and Vice President of Medical Affairs of Celgene Corporation. He served as the Chief Executive Officer of Celgene Global Health and Chief Medical Officer of Celgene Corporation. He has been employed at Celgene Corporation since 1997.
He has extensive drug development experience gained through his career at Celgene, Inc. He served as Assistant Professor of Medicine at the Harvard Medical School from July 1987 to September 1988, Associate Professor of Medicine at University of California, Davis from September 1988 to September 1994, Clinical Associate Professor of Medicine at Cornell Medical School from January 1995 to December 2003 and Professor of Clinical Medicine at the Robert Wood Johnson Medical School from July 1998 to June 2010. Dr. Zeldis served as an Associate Director of clinical research and Director of Medical Development at Sandoz Research Institute and Janssen Pharmaceutical Research Institute. From September 1994 to February 1997, he worked at Sandoz Research Institute and the Janssen Research Institute in both clinical research and medical development. He is an experienced global industry leader with a distinguished career at one of the world's leading biopharmaceutical companies with operations in more than 50 countries and products sold in more than 70 markets in the Americas, Europe and Asia Pacific regions. He has been the Chairman of Alliqua BioMedical, Inc., since November 29, 2012.
Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.
